Recap: Kiniksa Pharmaceuticals Q3 Earnings

Kiniksa Pharmaceuticals KNSA reported its Q3 earnings results on Tuesday, November 1, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Kiniksa Pharmaceuticals posted an EPS of $3.18.

Revenue was up $87.04 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.15 which was followed by a 9.46% increase in the share price the next day.

Here's a look at Kiniksa Pharmaceuticals's past performance:

 

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -0.44 -0.41 -0.42 -0.65
EPS Actual -0.29 -0.36 -0.53 -0.44
Revenue Estimate 28.55M 22.77M 20.72M 10.18M
Revenue Actual 26.97M 32.19M 18.75M 12.10M

To track all earnings releases for Kiniksa Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!